The standard of care for non-small cell lung cancer (NSCLC) is rapidly changing with recent advances in neoadjuvant, adjuvant, and perioperative immunotherapy for patients with early-stage disease. Join this expert discussion on the latest clinical data and guidelines to optimize multidisciplinary treatment selection, including surgery and immunotherapy. Put this knowledge into practice with evidence-based recommendations for using immunotherapy in the neoadjuvant, adjuvant, and perioperative settings in patients with early-stage NSCLC.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/when-surgery-meets-immunotherapy-advancing-care-patients-early-nsclc
- Start Date: 2024-02-29 06:00:00
- End Date: 2024-02-29 06:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest